Posts

Hims & Hers expects to establish a weight reduction company by year-end

Hims & Hers expects to establish a weight reduction com...

Aug 10, 2023

Hims & Hers, a company specializing in online health and wellness products, anno...

Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency

Merck and Ginkgo Forge $490 Million Partnership to Enha...

Aug 10, 2023

Merck has solidified a substantial collaboration valued at $490 million with Gin...

Phase 3 Approval of Novartis’ BTK Inhibitor Raises Concerns about Dupixent’s Risks

Phase 3 Approval of Novartis’ BTK Inhibitor Raises Conc...

Aug 10, 2023

Novartis is effectively navigating the competition to retain its foothold in the...

CD70 CAR-T by UTC Therapeutics for Mantle Cell Lymphoma...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Burkitt Lymphoma: Li...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Follicular Lymphoma:...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Anaplastic Large Cel...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for B-Cell Non-Hodgkin L...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Relapsed Chronic Lym...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Refractory Chronic L...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Marginal Zone B-cell...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

KKM-191-D by Genuone Science for Type 2 Diabetes: Likel...

Aug 10, 2023

KKM-191-D is under clinical development by Genuone Science and is currently in t...

JY-302 by Jin Yang Pharmaceutical for Type 2 Diabetes: ...

Aug 10, 2023

JY-302 is under clinical development by Jin Yang Pharmaceutical and is currently...

STAT+: Wegovy’s successful heart trial raises a vital question about weight loss

STAT+: Wegovy’s successful heart trial raises a vital q...

Aug 9, 2023

What exactly is the relationship between weight and health? A landmark study of ...

Failed clinical trials don’t always spell doom for a new drug. Here’s why

Failed clinical trials don’t always spell doom for a ne...

Aug 9, 2023

A failed trial isn’t always an automatic deal killer for a new drug, as clinical...

STAT+: ‘No data more personal’: Patients, digital health players weigh in on the FTC’s data privacy plan

STAT+: ‘No data more personal’: Patients, digital healt...

Aug 9, 2023

“We have so many people and things gathering data on us at all times, without an...